Mst1/2 |
Nkx2.5Cre/+;Mst1f/f; Mst2f/f |
Cardiomegaly due to increased cardiomyocyte proliferation. |
Heallen et al., 2011 |
|
Mst1–/–; Mst2–/– |
Developmental defects, Embryonic death between E9.5–E10.5. |
Oh et al., 2009; Song et al., 2010
|
|
CAGGCre–ER; Mst1–/–; Mst2f/–
|
Enlarged heart (partial penetrance). |
Song et al., 2010 |
|
αMHC-Mst1 Tg
|
Premature death (∼P15) due to heart failure, increased cardiomyocyte apoptosis, fibrosis and dilated cardiomyopathy. |
Yamamoto et al., 2003 |
|
αMHC-Mst1K59R Tg
|
No premature death, no sign of heart failure, reduced apoptosis after I/R injury, reduced apoptosis and fibrosis, no effect on cardiac hypertrophy. |
Yamamoto et al., 2003; Odashima et al., 2007
|
|
Mst2–/– |
No cardiac defects at the basal condition. Reduction of hypertrophy and fibrosis in response to pressure overload. |
Oh et al., 2009; Zi et al., 2014
|
|
Mst1–/– |
No cardiac defects at the basal condition. |
Oh et al., 2009 |
|
α-MHCMerCreMer:Mst1f/+
|
Decreased Angiotensin II-induced cardiomyocyte apoptosis. |
Cheng et al., 2019 |
Lats1/2 |
Lats2–/– |
Ventricular hypoplasia (partial penetrance). Embryonic lethality at E10.5. |
McPherson et al., 2004 |
|
Nkx2.5Cre/+;Lats2f/f |
Cardiomegaly due to increased cardiomyocyte proliferation. |
Heallen et al., 2011 |
|
α-MHC-Lats2 Tg
|
Reduction in the size of the left and right ventricles, reduced left ventricular systolic and diastolic function without affecting baseline apoptosis. |
Matsui et al., 2008 |
|
α-MHC-Lats2K697A Tg
|
Ventricular hypertrophy, reduced cardiac myocyte apoptosis induced by TAC. |
Matsui et al., 2008 |
|
Myh6CreERT2;Lats1f/f;Lats2f/f |
Increased cardiomyocyte proliferation, improved regeneration after apical resection. |
Heallen et al., 2013 |
|
Wt1CreERT2;Lats1f/f;Lats2f/f |
Embryonic lethality, defective coronary vasculature remodeling, and impaired differentiation into fibroblasts. |
Xiao et al., 2018 |
Sav1 |
Nkx2.5Cre/+;Salvf/f |
Cardiomegaly due to increased cardiomyocyte proliferation. |
Heallen et al., 2011 |
|
Myh6CreERT2;Salvf/f |
Increased cardiomyocyte renewal, increased cardiomyocyte proliferation, improved regeneration after apical resection or MI. |
Heallen et al., 2013 |